The purpose of the JECS, an ongoing prospective birth cohort study that began in 2011, is to evaluate the impact of various environmental factors on children’s health and development [ 5 , 6 ]. A total of 100,000 children and their parents took part across 15 regions in Japan with follow-up programs to examine health periodically from the early stages of pregnancy until the participating child reaches 13 years of age. The present study is based on the dataset of jecs-ag-ai-20131008, which was released in October 2013. Enrollment started on 24 January 2011 and ended on 31 March 2014. All participants provided their written, informed consent. The current study is considered as a part of the JECS study. All adjunct studies are not required to have patient’s approval because it has been already written in the original consent.
The JECS protocol was approved by the Institutional Review Board (IRB) on epidemiological studies of the Ministry of the Environment (MOE) and the Ethics Committees of all participating institutions. The jecs-ag-ai-20131008 dataset does not contain any patient identifying information. This study was conducted under the approval of the JECS as an adjunct study. It has obtained the written consent approved by MOE, ensuring that they do not interfere with the main study of the JECS. We sought an approval from the ethics committee of the national center for japan environmental and children’s study.
The JECS is a national project which was designed to improve children’s health and development. The MOE instituted a general rule to open the jecs-ag-ai-20131008 dataset. Any researcher can use the dataset after seeking permission from the MOE. The email address is
[email protected] to contact details for inquiries about JECS.
The JECS participants were enrolled before delivery. A research coordinator described the JECS to the pregnant women after calculating the estimated date of delivery by ultrasound based on the crown lump length. In this study, each woman completed a questionnaire regarding her past history of endometriosis, reporting whether she had been diagnosed with endometriosis during the past year, ever had endometriosis, and ever received infertility treatment. This study did not take into account the period between diagnosis of endometriosis and the occurrence of pregnancy. Trained research coordinators collected data concerning obstetrical complications and neonatal outcomes from medical records in the obstetrics institutions.
Included in this study were 9,186 pregnant women in the JECS with or without a history of endometriosis who gave birth, stillbirth, or whose pregnancy was terminated with abortion between February and December 2011. They were diagnosed with a single pregnancy in the first trimester by transvaginal ultrasound in the hospitals. Cases of multiple pregnancies were excluded.
Maternal age was defined as age in completed years at the time of delivery and was categorized as <20, 20–24, 25–29, 30–34, 35–39, or 40 years and older. Women were classified as non-smokers, ex-smokers, current smokers, and those exposed to passive smoke, and they were sorted into < 3 days/week and ≥ 3 days/week. Alcohol drinking was defined as non-drinking, ex-drinking, and current drinking. ART therapy included information about in vitro fertilization (IVF) treatment, intracytoplasmic sperm injection (ICSI), frozen-thawed embryo transfer, and blastocyst embryo transfer for the present pregnancy. ART did not include artificial insemination with the husband’s semen (AIH).
Complications of pregnancy were characterized as threatened abortion, threatened premature delivery, premature rupture of the membranes (PROM), gestational diabetes, preeclampsia, placenta previa, placental abruption, fetal growth restriction (FGR), and non-reassuring fetal status (NRFS). Neonatal outcomes were defined as livebirth, abortion, and stillbirth.
Threatened abortion was diagnosed by clinical symptoms, such as genital bleeding, lower abdominal pain, a shortened cervix before 22 weeks’ gestation, and threatened premature delivery from 22 to 37 weeks’ gestation. Non-reassuring fetal status (NRFS) was defined by doctors as an abnormal fetal heartbeat monitored during labor, classified as an FHR pattern level of 3 to 5 (mild, moderate, and severe variant patterns) using a combination of three factors: the baseline variability, the baseline, and the presence of various decelerations [ 7 ]. Preeclampsia was defined as persistently raised blood pressure ≥140/90 mmHg, occurring after >20 weeks of pregnancy in an otherwise normotensive woman, including gestational hypertension (preeclampsia without proteinuria), and gestational proteinuria (preeclampsia with proteinuria of ≥300 mg protein in 24 h) [ 7 ]. Preeclampsia with severe features was defined as severe blood pressure elevation (systolic blood pressure ≥ 160 mmHg or diastolic ≥ 110 mm Hg) and severe proteinuria (≥ 2,000 mg protein in 24 h).
The pregnant women with gestational diabetes (GD) were screened by the following stepwise method in Japan. Firstly, the random blood glucose levels were measured at early stage of pregnancy (each hospital should determine its own cut-off value). A 50-g glucose challenge test was given to the pregnant women (cut-off value ≥140 mg/dL) or the random glucose levels were measured for the second time (cut-off value ≥100 mg/dL) between 24 and 28 weeks. The pregnant women with a positive screening test result were tested for 75-g oral glucose tolerance test (OGTT). Gestational diabetes is defined as the pregnant woman having fulfilled one or more threshold values of a 75-g OGTT. Threshold values for 75-g OGTT are fasting plasma glucose (FPG) ≥ 92 mg/dL, 1-h PG ≥ 180 mg/dL, and 2-h PG ≥ 153 mg/dL [ 7 ]. FGR was defined as below the −1.5 SD value of the mean estimated fetal weight (EFW). Abortion was defined as termination of a pregnancy caused by spontaneous abortion or medical means prior to 22 weeks of gestation. Stillbirth is commonly defined as the death of a fetus at 22 or more weeks’ gestation that died before or during delivery.
The Wilcoxon rank-sum test and the chi-squared test were used to evaluate whether there were significant differences in age, smoking, passive smoking, alcohol drinking, gestational age, and other clinical characteristics between women with and without endometriosis. To compare the incidence of complications of pregnancy in women with and without endometriosis, Fisher’s exact test and logistic regression analysis were used. To examine the interaction between endometriosis and fertility treatment, all women were grouped into one of four combination groups: Group-A1, as the reference group, women without a history of endometriosis and without infertility treatment group; Group-A2, women with endometriosis and without infertility treatment; Group-A3, women without endometriosis and with infertility treatment; and Group-A4, women with endometriosis and with infertility treatment. Unconditional logistic regression models were used to estimate age-adjusted odds ratios (ORs) and their 95% confidence intervals (CIs). To examine the interaction between endometriosis and ART therapy, women were also grouped into four combination groups: Group-B1, as the reference group, women without a history of endometriosis who conceived naturally or conceived after infertility treatment, except for ART therapy; Group-B2, women with endometriosis and without ART therapy; Group-B3, women without endometriosis and with ART therapy; and Group-B4, women with both endometriosis and ART therapy. We restricted the analyses population to the pregnancies with complete covariate data. All analyses were performed using SAS V.9.4 (SAS Institute Inc., Cary, NC, USA). A value of p<0.05 was considered significant for every statistical analysis.